Rupture: Clinical Trials

5 trials for Rupture, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 terminated. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Terminated 5
Phase 21Terminated 1

Follow Rupture: new trials by email Literature Review of Rupture trials Research Report on Rupture

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH
EG-1962 (nimodipine microparticles), Enteral Nimodipine - Subarachnoid Hemorrhage, Aneurysmal
Phase 1TerminatedEdge Therapeutics Inc62016-09-012018-07-26
Utilization of AMSC to Enhance Rotator Cuff Repair - Safety and Efficacy
Suspension of human autologous MSC 3P - Rotator Cuff Tear
Phase 1 / Phase 2TerminatedBioinova, s.r.o.92012-12-122019-02-15
Platelet Rich Plasma vs. Corticosteroid Injection in the Treatment of Partial Rotator Cuff Tears
Platelet Rich Plasma (PRP), Corticosteroid - Rotator Cuff Tear
Phase 1TerminatedUniversity of North Carolina, Chapel Hill122012-11-012017-04-17
Study Evaluating Safety Of BMP-655/ACS As An Adjuvant Therapy For Rotator Cuff Repair
BMP-655/ACS or Standard of Care - Rotator Cuff Tear
Phase 1TerminatedPfizer132010-09-012012-04-13
A Safety Study Of BMP-655/ACS As An Adjuvant Therapy For Treatment Of Rotator Cuff Tears
BMP-655/ACS+Standard of care or Standard of care - Rotator Cuff Tear
Phase 1TerminatedPfizer232010-06-012013-02-22

Narrower conditions

Rotator Cuff Injuries (4)  ·  Aneurysm (1)  ·  Subarachnoid Hemorrhage (1)

Broader conditions

Wounds and Injuries (5)  ·  Shoulder Injuries (4)  ·  Tendon Injuries (4)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Hemorrhage (1)  ·  Intracranial Hemorrhages (1)  ·  Nervous System Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Vascular Diseases (1)

Interventions

Standard of Care (2)  ·  Adrenal Cortex Hormones (1)  ·  Bupivacaine (1)  ·  Dexamethasone (1)  ·  EG-1962 (1)  ·  Triamcinolone Acetonide (1)

Sponsors

Pfizer (2)  ·  Bioinova, s.r.o. (1)  ·  Edge Therapeutics Inc (1)  ·  University of North Carolina, Chapel Hill (1)

Countries

United States (2)  ·  Canada (1)  ·  Germany (1)  ·  Japan (1)  ·  Netherlands (1)

Top investigators

Berkoff David, MD (1)  ·  Brendan C Mackinnon-Patterson, BS, MPH, MD (1)  ·  Petr Lesny, MD (1)  ·  R. Loch Macdonald, MD, PhD (1)

Results publications

PMID 28932752, PMID 32985652, PMID 37624739